Gabelli & Co Investment Advisers’s Zura Bio ZURA Stock Holding History

Gabelli & Co Investment Advisers’s Portfolio ZURA Stock Details ZURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-91,400	Closed	-$933K	–	253
2022 Q4	$933K	Hold	91,400	–	–	0.2%	81
2022 Q3	$919K	Hold	91,400	–	–	0.12%	128
2022 Q2	$909K	Hold	91,400	–	–	0.12%	135
2022 Q1	$906K	Hold	91,400	–	–	0.12%	141
2021 Q4	$902K	Hold	91,400	–	–	0.12%	135
2021 Q3	$894K	Buy	+91,400	New	+$897K	0.11%	147

Other funds holding ZURA

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

SAMU

SONA Asset Management (US) New York $4.74B AUM 11.18% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Gabelli & Co Investment Advisers's ZURA Position: Q1 2023 in Review

Gabelli & Co Investment Advisers sold out of Zura Bio (ZURA) in Q1 2023, closing a stake of 91,400 shares — an estimated $933K sold.

Gabelli & Co Investment Advisers first reported a position in ZURA in Q3 2021 and held it in 6 quarters. The position peaked at $933K in Q4 2022. 3 funds tracked by Wall St. Rank hold ZURA as of Q1 2023.

Gabelli & Co Investment Advisers reported no remaining Zura Bio position as of Q1 2023 after selling out during the quarter.
Gabelli & Co Investment Advisers sold 91,400 Zura Bio shares in Q1 2023, an estimated $933K.
Gabelli & Co Investment Advisers first reported a position in Zura Bio in Q3 2021 and held it in 6 quarters.
Gabelli & Co Investment Advisers's Zura Bio position peaked at $933K in Q4 2022.
3 funds tracked by Wall St. Rank held Zura Bio as of Q1 2023.

Based on Gabelli & Co Investment Advisers's 13F filing for Q1 2023, filed 12 May 2023.